349 related articles for article (PubMed ID: 35897750)
21. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.
Giuliani AL; Colognesi D; Ricco T; Roncato C; Capece M; Amoroso F; Wang QG; De Marchi E; Gartland A; Di Virgilio F; Adinolfi E
PLoS One; 2014; 9(9):e107224. PubMed ID: 25226385
[TBL] [Abstract][Full Text] [Related]
22. Progress in the relationship between P2X7R and colorectal cancer.
Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of antigen receptor-dependent Ca(2+) signals and NF-AT activation by P2X7 receptors in human B lymphocytes.
Pippel A; Beßler B; Klapperstück M; Markwardt F
Cell Calcium; 2015 Apr; 57(4):275-89. PubMed ID: 25678443
[TBL] [Abstract][Full Text] [Related]
24. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
25. P2X7 receptors: role in bone cell formation and function.
Agrawal A; Gartland A
J Mol Endocrinol; 2015 Apr; 54(2):R75-88. PubMed ID: 25591582
[TBL] [Abstract][Full Text] [Related]
26. Human beta-defensin-2 and -3 enhance pro-inflammatory cytokine expression induced by TLR ligands via ATP-release in a P2X7R dependent manner.
Wanke D; Mauch-Mücke K; Holler E; Hehlgans T
Immunobiology; 2016 Nov; 221(11):1259-65. PubMed ID: 27377709
[TBL] [Abstract][Full Text] [Related]
27. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
Humphreys BD; Virginio C; Surprenant A; Rice J; Dubyak GR
Mol Pharmacol; 1998 Jul; 54(1):22-32. PubMed ID: 9658186
[TBL] [Abstract][Full Text] [Related]
28. A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22.
Engel T; Brennan GP; Sanz-Rodriguez A; Alves M; Beamer E; Watters O; Henshall DC; Jimenez-Mateos EM
Biochim Biophys Acta Mol Cell Res; 2017 Feb; 1864(2):255-266. PubMed ID: 27840225
[TBL] [Abstract][Full Text] [Related]
29. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
30. Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice.
Le Gall SM; Legrand J; Benbijja M; Safya H; Benihoud K; Kanellopoulos JM; Bobé P
PLoS One; 2012; 7(12):e52161. PubMed ID: 23284917
[TBL] [Abstract][Full Text] [Related]
31. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
[TBL] [Abstract][Full Text] [Related]
32. P2X
Golia MT; Gabrielli M; Verderio C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372953
[TBL] [Abstract][Full Text] [Related]
33. Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor.
Xu P; Xu Y; Hu B; Wang J; Pan R; Murugan M; Wu LJ; Tang Y
Brain Behav Immun; 2015 Nov; 50():87-100. PubMed ID: 26122280
[TBL] [Abstract][Full Text] [Related]
34. Purinergic P2X7R as a potential target for pancreatic cancer.
Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X
Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920
[TBL] [Abstract][Full Text] [Related]
35. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.
Bianchi G; Vuerich M; Pellegatti P; Marimpietri D; Emionite L; Marigo I; Bronte V; Di Virgilio F; Pistoia V; Raffaghello L
Cell Death Dis; 2014 Mar; 5(3):e1135. PubMed ID: 24651438
[TBL] [Abstract][Full Text] [Related]
36. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
37. P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.
Bianchi C; Alvarez-Castelao B; Sebastián-Serrano Á; Di Lauro C; Soria-Tobar L; Nicke A; Engel T; Díaz-Hernández M
Alzheimers Res Ther; 2023 Jun; 15(1):105. PubMed ID: 37287063
[TBL] [Abstract][Full Text] [Related]
38. New role of P2X7 receptor in an Alzheimer's disease mouse model.
Martin E; Amar M; Dalle C; Youssef I; Boucher C; Le Duigou C; Brückner M; Prigent A; Sazdovitch V; Halle A; Kanellopoulos JM; Fontaine B; Delatour B; Delarasse C
Mol Psychiatry; 2019 Jan; 24(1):108-125. PubMed ID: 29934546
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
[TBL] [Abstract][Full Text] [Related]
40. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival.
Gehring MP; Kipper F; Nicoletti NF; Sperotto ND; Zanin R; Tamajusuku AS; Flores DG; Meurer L; Roesler R; Filho AB; Lenz G; Campos MM; Morrone FB
Int J Biochem Cell Biol; 2015 Nov; 68():92-100. PubMed ID: 26358881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
